Projects | SRI International

Toggle Menu


chemical diagram
SRI is developing a new therapeutic agent for influenza virus infections.
SRI is elucidating the mechanism of action of the drug of choice for the treatment of all known forms of human schistosomiasis.
graphic showing the hypothetical pharmacophore features for herboxidiene
SRI researchers are searching for new molecular targets that allow for discovery of more selective anticancer agents.